<?xml version="1.0" encoding="UTF-8"?>
<p id="para0015">An important but unanswered question is the effect of COVID-19 on pregnant women as they are prone to many infections because of their suppressed immune systems (
 <xref rid="bib0016" ref-type="bibr">Favre et al., 2020</xref>; 
 <xref rid="bib0045" ref-type="bibr">Schwart and Graham, 2020</xref>; 
 <xref rid="bib0047" ref-type="bibr">Wang et al., 2020</xref>). A recent analysis of previous outbreaks of SARS and MERS highlighted that there were no confirmed cases of maternal-fetal transmission (
 <xref rid="bib0045" ref-type="bibr">Schwart and Graham, 2020</xref>). Out of the twelve pregnant women who were infected with SARS, four had miscarriages in the first trimester, two each had a newborn with intrauterine growth restrictions in the second and third trimesters, four had preterm births, and two women died during their pregnancies (
 <xref rid="bib0045" ref-type="bibr">Schwart and Graham, 2020</xref>). A review of 11 pregnant women who were infected with MERS revealed that 91% had poor obstetrical outcomes (i.e. premature delivery, neonatal mortality, and severe respiratory disease) (
 <xref rid="bib0016" ref-type="bibr">Favre et al., 2020</xref>). Hence, both SARS and MERS infections were associated with aversive obstetrical outcomes but not maternal-fetal intrauterine transmissions.
</p>
